查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888711

基於 CRISPR 的即時診斷市場規模、佔有率和趨勢分析報告：按產品、技術、應用、最終用途、地區和細分市場預測（2025-2033 年）

CRISPR-based POC Diagnostics Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

基於 CRISPR 的即時診斷市場摘要

2024 年全球基於 CRISPR 的即時診斷市場規模估計為 5.0264 億美元，預計到 2033 年將達到 17.8656 億美元。

預計從 2025 年到 2033 年，該市場將以 15.41% 的複合年成長率成長。隨著診斷能力向醫療點靠攏，市場正在擴張，這主要得益於醫療基礎設施有限的地區擴大採用檢測方法。

成本效益高、準確度高、操作簡便，正推動其在全球醫療系統中廣泛應用。戰略合作正將創新帶入市場，尤其是在醫療資源匱乏的地區。例如，2023年8月，Crisprbits與Molbio Diagnostics Limited合作推出了一款基於CRISPR技術的就地檢驗，該產品提供了一種經濟高效、創新且高度精準的診斷解決方案，同時拓展了市場機遇，並革新了照護現場。

此外，感染疾病流行是推動市場成長的主要因素。包括流感、結核病、病毒性肝炎和性行為感染感染（STI）在內的全球感染疾病負擔正在穩定加重，因此迫切需要快速、準確且低成本的診斷解決方案。 2025年2月，世界衛生組織指出，季節性流感仍是重要的全球健康問題，每年報告的病例估計達10億例（其中300萬至500萬例為重症）。這種感染疾病每年導致29萬至65萬人死於呼吸道疾病，凸顯了其對全球公共衛生系統造成的毀滅性影響。尤其值得注意的是，99%的五歲以下兒童流感相關下呼吸道感染疾病死亡病例發生在開發中國家，這凸顯了醫療保健服務取得和治療結果方面存在的嚴重差距。此外，世界衛生組織於2025年9月宣布，全球15至49歲人口每天感染超過100萬例可治療的性行為感染（STI），其中大多數為無症狀感染者。據估計，到2022年，約有800萬15至49歲成年人將感染梅毒。

此外，由於全球遺傳疾病負擔日益加重，以及對快速、準確且經濟高效的檢測需求不斷成長，市場正在迅速擴張。傳統的PCR和RT-PCR方法雖然準確，但需要複雜的設備、訓練有素的人員以及較長的檢測時間，這限制了它們在資源有限和分散式環境中的實用性。 CRISPR/Cas系統（Cas9、Cas12和Cas13）具有無與倫比的靈敏度、特異性和可程式設計，能夠在1小時內以單核苷酸解析度檢測癌症和基因突變。諸如SHERLOCK和DETECTR之類的平台透過簡單的側向流動或螢光檢測方法即可實現阿托莫耳級的靈敏度，使其成為照護現場（POC）的理想選擇。 CRISPR診斷技術將分子層面的準確性與操作簡便性和擴充性結合，正在改變全球診斷格局，並推動其在醫院、診所和分散式檢查項目中的應用。

此外，全球亟需解決抗菌素抗藥性（AMR）問題，這是現代醫療保健領域最迫切的挑戰之一，也推動了對基於CRISPR技術的即時診斷的需求。世界各地的醫院和醫療保健系統都面臨越來越大的壓力，需要快速檢測和控制抗藥性感染疾病，以防止代價高昂的疫情爆發並改善患者預後。基於CRISPR技術的診斷提案具有強大的價值：它們提供快速、高度準確且易於使用的檢測解決方案，從而減少對中心實驗室的依賴。這些技術使臨床醫生能夠做出早期且準確的治療決策，最大限度地減少抗生素濫用並最佳化資源利用。其便攜性和擴充性使其對資源有限的環境和即時診斷應用尤為具有吸引力。 CRISPR診斷技術兼具準確性、速度和易用性，正在革新感染疾病診斷市場，並為臨床決策效率樹立新的標準。例如，2025年2月，印度Crisprbits公司開發了PathCrisp，這是一個用於檢測院內感染中抗生素抗藥性的分子診斷平台。該技術旨在實現對抗菌素抗藥性（AMR）的早期檢測，這是一個全球性的健康問題，尤其是在加護病房（ICU）中。

目錄

第1章 基於CRISPR技術的即時診斷市場：調查方法與範圍

2. 基於 CRISPR 的即時診斷市場：執行摘要

  • 市場概覽
  • 產品
  • 技術概述
  • 應用概述
  • 最終用途概述
  • 競爭格局概述

3. 基於 CRISPR 的即時診斷市場的變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
    • 去中心化且易於使用的診斷技術
    • 全球感染疾病和遺傳疾病負擔日益加重
    • 應對抗菌素抗藥性（AMR）的迫切需求
  • 市場限制因素分析
    • 監管和臨床檢驗障礙
    • 生產擴充性和成本限制
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章 基於 CRISPR 的即時診斷市場：按產品分類的估算和趨勢分析

  • 基於 CRISPR 的即時診斷市場：產品差異分析
  • 設備/器材
  • 檢測試劑盒和試劑
  • 軟體和連接平台

第5章 基於 CRISPR 的即時診斷市場：按技術分類的估算和趨勢分析

  • 基於 CRISPR 的即時診斷市場：按技術分類的差異分析
  • 基於Cas9的
  • 基於 Cas12 的（DETECTR 技術）
  • 基於 Cas13 的（SHERLOCK 技術）
  • 其他新興的Cas系統

第6章 基於 CRISPR 的即時診斷市場：按應用分類的估算和趨勢分析

  • 基於 CRISPR 的即時診斷市場：按應用分類的差異分析
  • 感染疾病診斷
  • 基因疾病檢測
  • 腫瘤診斷
  • 抗菌素抗藥性（AMR）檢測
  • 其他用途

7. 基於 CRISPR 的即時診斷市場：按最終用途分類的估算和趨勢分析

  • 基於 CRISPR 的即時診斷市場：按最終用途分類的差異分析
  • 醫院和診所
  • 診斷檢查室
  • 居家照護/居家檢測
  • 其他

8. 基於 CRISPR 的即時診斷市場：區域業務分析

  • 區域市場概覽
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第9章 競爭情勢

  • 公司分類
  • 策略規劃
    • 新產品發布
    • 合夥
    • 獲得
    • 合資
    • 資金籌措
  • 主要企業市佔率分析（2024 年）
  • 公司熱力圖分析
  • 公司簡介
    • Mammoth Biosciences, Inc.
    • OraSure Technologies, Inc.（Sherlock Biosciences）
    • Caspr Biotech
    • GenScript
    • Integrated DNA Technologies, Inc.
    • Synthego
    • Revvity Discovery Limited
    • Twist Bioscience
    • Crisprbits
    • Danaher Corporation（Cepheid）
Product Code: GVR-4-68040-820-3

CRISPR-based POC Diagnostics Market Summary

The global CRISPR-based POC diagnostics market size was estimated at USD 502.64 million in 2024 and is projected to reach USD 1,786.56 million by 2033, growing at a CAGR of 15.41% from 2025 to 2033. The market is expanding as diagnostic capabilities shift closer to the point of care, supported by broader availability of testing in regions with limited healthcare infrastructure.

Cost-effectiveness, high accuracy, and ease of use propel adoption across healthcare systems globally. Strategic partnerships are bringing innovations into the market, specifically in underserved settings. For instance, in August 2023, Crisprbits partnered with Molbio Diagnostics Limited to launch CRISPR-based point-of-care tests to provide cost-effective, innovative, and highly accurate diagnostic solutions while expanding market opportunities and transforming point-of-care diagnostics.

Furthermore, the increasing prevalence of infectious diseases is a major factor propelling the growth of the market. The global burden of infectious conditions such as influenza, tuberculosis, viral hepatitis, and sexually transmitted infections (STIs) has risen steadily, creating an urgent need for rapid, accurate, and affordable diagnostic solutions. In February 2025, the WHO noted that seasonal influenza continues to pose a significant global health burden, with an estimated one billion cases reported annually, including 3-5 million cases of severe illness. The infection is responsible for 290,000 to 650,000 respiratory deaths each year, underscoring its substantial impact on public health systems worldwide. Significantly, 99% of influenza-related lower respiratory tract infection deaths among children under five occur in developing countries, highlighting stark inequalities in healthcare access and outcomes. Moreover, the WHO stated in September 2025 that every day, more than 1 million treatable sexually transmitted infections (STIs) are acquired in people aged 15 to 49 worldwide, with the majority of them asymptomatic. In 2022, an estimated 8 million adults aged 15 to 49 were infected with syphilis.

In addition, the market is expanding rapidly due to the increasing global burden of genetic diseases and the growing demand for rapid, accurate, and cost-effective testing. Traditional PCR and RT-PCR methods, although precise, require sophisticated equipment, trained personnel, and lengthy turnaround times, which limit their utility in resource-constrained and decentralized settings. CRISPR/Cas systems (Cas9, Cas12, and Cas13) offer unparalleled sensitivity, specificity, and programmability, enabling the detection of cancers and genetic variants with single-nucleotide resolution within an hour. Platforms like SHERLOCK and DETECTR have achieved attomolar sensitivity with simple lateral flow or fluorescence readouts, making them excellent candidates for point-of-care applications. CRISPR diagnostics, which combine molecular precision with operational simplicity and scalability, are reshaping the global diagnostics landscape and driving adoption in hospitals, clinics, and decentralized testing programs.

Moreover, the growing global urgency to address antimicrobial resistance (AMR), which has become one of the most important challenges in modern healthcare, is boosting the demand for the CRISPR-based POC diagnostics. Hospitals and healthcare systems worldwide are under increasing pressure to rapidly detect and contain antibiotic-resistant infections, thereby preventing costly outbreaks and improving patient outcomes. CRISPR-based diagnostic platforms offer a compelling value proposition by delivering fast, highly accurate, and easy-to-use testing solutions that reduce reliance on centralized laboratory facilities. These technologies enable clinicians to make early and targeted treatment decisions, minimizing the misuse of antibiotics and optimizing resource utilization. Their portability and scalability make them particularly attractive for deployment in resource-limited settings and point-of-care environments. By combining precision, speed, and accessibility, CRISPR diagnostics are revolutionizing the infectious disease diagnostics market and establishing new benchmarks for efficiency in clinical decision-making. For instance, in February 2025, Crisprbits (India) developed PathCrisp, a molecular diagnostic platform that uses CRISPR technology to detect antibiotic resistance in hospital-acquired infections. The technology is intended to allow early identification of AMR, a major worldwide health concern, particularly in intensive care units (ICUs).

Global CRISPR-based POC Diagnostics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global CRISPR-based POC diagnostics market report based on product, technology, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments/Devices
  • Assay Kits and Reagents
  • Software and Connectivity Platforms
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Cas9-Based
  • Cas12-Based (DETECTR Technology)
  • Cas13-Based (SHERLOCK Technology)
  • Other Emerging Cas Systems
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Infectious Disease Diagnostics
  • Genetic Disorder Testing
  • Oncology Diagnostics
  • Antimicrobial Resistance (AMR) Testing
  • Other Applications
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Homecare / At-Home Testing
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. CRISPR-based POC Diagnostics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Application Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. CRISPR-based POC Diagnostics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product
  • 2.3. Technology Snapshot
  • 2.4. Application Snapshot
  • 2.5. End Use Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. CRISPR-based POC Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Decentralized and accessible diagnostics
    • 3.4.2. Rising global burden of infectious and genetic diseases
    • 3.4.3. Growing need to combat antimicrobial resistance (AMR)
  • 3.5. Market Restraint Analysis
    • 3.5.1. Regulatory and clinical validation barriers
    • 3.5.2. Manufacturing scalability and cost constraints
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. CRISPR-based POC Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. CRISPR-based POC Diagnostics Market: Product Movement Analysis
  • 4.2. Instruments/Devices
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Assay Kits and Reagents
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Software and Connectivity Platforms
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. CRISPR-based POC Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. CRISPR-based POC Diagnostics Market: Technology Movement Analysis
  • 5.2. Cas9-Based
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Cas12-Based (DETECTR Technology)
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Cas13-Based (SHERLOCK Technology)
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Other Emerging Cas Systems
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. CRISPR-based POC Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. CRISPR-based POC Diagnostics Market: End Use Movement Analysis
  • 6.2. Infectious Disease Diagnostics
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Genetic Disorder Testing
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Oncology Diagnostics
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Antimicrobial Resistance (AMR) Testing
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Other Applications
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. CRISPR-based POC Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. CRISPR-based POC Diagnostics Market: End Use Movement Analysis
  • 7.2. Hospitals and Clinics
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Homecare / At-Home Testing
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Others
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. CRISPR-based POC Diagnostics Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America CRISPR-based POC Diagnostics Market Estimates and Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. Middle East & Africa
    • 8.6.1. Middle East & Africa CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait CRISPR-based POC Diagnostics Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. New Product Launch
    • 9.2.2. Partnerships
    • 9.2.3. Acquisition
    • 9.2.4. Collaboration
    • 9.2.5. Funding
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. Mammoth Biosciences, Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. OraSure Technologies, Inc. (Sherlock Biosciences)
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Caspr Biotech
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. GenScript
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Integrated DNA Technologies, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Synthego
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Revvity Discovery Limited
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Twist Bioscience
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Crisprbits
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Danaher Corporation (Cepheid)
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global CRISPR-based POC Diagnostics Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Global CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 6 Global CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 Global CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 11 North America CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 12 North America CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 15 U.S. CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 U.S. CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 Canada CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 19 Canada CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 Canada CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 23 Mexico CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 Mexico CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Europe CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 28 Europe CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Europe CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 UK CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 32 UK CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 UK CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Germany CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 36 Germany CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 37 Germany CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 France CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 40 France CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 France CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Italy CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 44 Italy CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Italy CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Spain CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 48 Spain CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 Spain CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Sweden CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 52 Sweden CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 53 Sweden CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 Norway CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 56 Norway CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 Norway CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Denmark CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 60 Denmark CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 Denmark CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 65 Asia-Pacific CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Japan CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 69 Japan CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 70 Japan CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 China CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 73 China CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 China CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 76 India CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 77 India CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 78 India CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 Australia CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 81 Australia CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 82 Australia CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 Thailand CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 85 Thailand CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 Thailand CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 South Korea CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 89 South Korea CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 South Korea CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 94 Latin America CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 Latin America CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 98 Brazil CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 99 Brazil CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 102 Argentina CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 103 Argentina CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 Middle East & Africa CRISPR-based POC Diagnostics Market, By Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East & Africa CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 106 Middle East & Africa CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 107 Middle East & Africa CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 111 South Africa CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 112 South Africa CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 UAE CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 119 UAE CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 120 UAE CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait CRISPR-based POC Diagnostics Market, By Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait CRISPR-based POC Diagnostics Market, By Technology, 2021 - 2033 (USD Million)
  • Table 123 Kuwait CRISPR-based POC Diagnostics Market, By Application, 2021 - 2033 (USD Million)
  • Table 124 Kuwait CRISPR-based POC Diagnostics Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global CRISPR-based POC diagnostics market - Key market driver analysis
  • Fig. 7 Global CRISPR-based POC diagnostics market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global CRISPR-based POC diagnostics market - Porter's analysis
  • Fig. 10 Global CRISPR-based POC diagnostics market - PESTEL analysis
  • Fig. 11 Global CRISPR-based POC diagnostics market: Product outlook key takeaways
  • Fig. 12 Global CRISPR-based POC diagnostics market: Product movement analysis
  • Fig. 13 Instruments/devices market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Assay kits and reagents market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Software and connectivity platforms market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Global CRISPR-based POC diagnostics market: Technology outlook key takeaways
  • Fig. 17 Global CRISPR-based POC diagnostics market: Technology movement analysis
  • Fig. 18 Cas9-based market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Cas12-based (DETECTR technology) market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Cas13-based (SHERLOCK technology) market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Other emerging Cas systems market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Global CRISPR-based POC diagnostics market: Application outlook key takeaways
  • Fig. 23 Global CRISPR-based POC diagnostics market: Application movement analysis
  • Fig. 24 Infectious disease diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 25 Genetic disorder testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Oncology diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Antimicrobial resistance (AMR) testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Other applications market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Global CRISPR-based POC diagnostics market: End Use outlook key takeaways
  • Fig. 30 Global CRISPR-based POC diagnostics market: End Use movement analysis
  • Fig. 31 Hospitals and clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Diagnostic laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Homecare / at-home testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 Global CRISPR-based POC diagnostics market: Regional movement analysis
  • Fig. 37 North America CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 39 Canada CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 40 Mexico CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 41 Europe CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 42 UK CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 44 France CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 46 Italy CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 47 Denmark CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 48 Sweden CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 49 Norway CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 50 Asia Pacific CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 51 Japan CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 52 China CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 53 India CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 54 South Korea CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 55 Australia CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 56 Thailand CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 57 Latin America CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 58 Brazil CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 59 Argentina CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 60 Middle East & Africa CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 61 South Africa CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 62 Saudi Arabia CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 63 UAE CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 64 Kuwait CRISPR-based POC diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 65 Strategy framework